Cervenka_2015_Clin.Exp.Pharmacol.Physiol_42_795

Reference

Title : Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula - Cervenka_2015_Clin.Exp.Pharmacol.Physiol_42_795
Author(s) : Cervenka L , Melenovsky V , Huskova Z , Skaroupkova P , Nishiyama A , Sadowski J
Ref : Clinical & Experimental Pharmacology & Physiology , 42 :795 , 2015
Abstract : Cervenka_2015_Clin.Exp.Pharmacol.Physiol_42_795
ESTHER : Cervenka_2015_Clin.Exp.Pharmacol.Physiol_42_795
PubMedSearch : Cervenka_2015_Clin.Exp.Pharmacol.Physiol_42_795
PubMedID: 25969338

Related information

Citations formats

Cervenka L, Melenovsky V, Huskova Z, Skaroupkova P, Nishiyama A, Sadowski J (2015)
Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula
Clinical & Experimental Pharmacology & Physiology 42 :795

Cervenka L, Melenovsky V, Huskova Z, Skaroupkova P, Nishiyama A, Sadowski J (2015)
Clinical & Experimental Pharmacology & Physiology 42 :795